Do You Need a License to Sell Peptides in Indiana?

If you are operating a business in Indiana, you generally need the ordinary business permissions any seller needs — a registered entity, a state tax and retail merchant registration, and whatever your county or municipality requires. Beyond that baseline, whether anything further applies depends on how the specific product is classified and what you are doing with it, not on the fact that the molecule happens to be a peptide. Research-use-only materials sold business-to-business for laboratory work sit in a different lane from products handled as drugs intended for administration to people, and that second lane pulls in pharmacy, wholesale drug distribution, and professional licensing questions that only an Indiana attorney and the relevant state board can answer for your specific model. This article is informational and is not legal advice.

"Peptide" is a chemistry word, not a regulatory category

A peptide is simply a short chain of amino acids. That describes the molecule; it does not describe a regulatory status. Nothing in the word tells a regulator whether an item is a laboratory reagent, a dietary ingredient, a cosmetic ingredient, or something handled as a drug.

What does the sorting is a combination of factors: how the product is labeled, what claims appear in your catalog and marketing, who you sell it to, and what you say it is for. Two businesses can hold the same vial and be in entirely different regulatory positions because one describes it as research material for laboratory use and the other describes it as something a person should take.

This is why "do I need a license to sell peptides" almost never has a clean yes-or-no answer. The honest answer is that you first have to decide precisely what you are selling and how you will describe it, then bring that description — in writing, with your actual label and web copy attached — to counsel. Guessing at the answer and reverse-engineering the copy later is how businesses end up with problems.

Three separate questions hide inside one

Most operators asking about licensure are actually asking three different questions at once, and each is answered by a different body.

Can I lawfully operate and sell as a business? This is the baseline. In most states, including Indiana, entity formation runs through the secretary of state and sales tax registration runs through the department of revenue, with local registrations layered on top. This part is routine and applies whether you are selling reagents, retail goods, or services. Confirm the current requirements directly with those offices or your accountant.

Does the specific product I am handling trigger additional licensure? This is the question that matters most and the one people skip. If a product is classified in a way that puts it under drug distribution rules, activities like warehousing, reselling, or shipping it can implicate wholesale distributor or pharmacy licensure. State boards of pharmacy are generally the authority on that question in most states, and the answer can turn on details of your specific inventory and supply chain. Do not assume; ask.

Am I doing something that crosses into licensed practice? Offering services to people, making health claims, or operating under a medical director's authority raises scope-of-practice questions that belong to professional licensing boards and your counsel — not to your supplier. A vendor cannot tell you what your clinical license permits, and any vendor that tries to is telling you more than it can know.

Separating these three questions makes the research tractable. Bundled together, they produce the vague anxiety that keeps otherwise capable operators from ever placing a first order.

Where to take each question

Use this as a routing map for your own diligence, not as a statement of what Indiana law requires in your situation.

Every cell in that table is a conversation you can have in a week. Collectively they are cheaper than one enforcement letter, and far cheaper than a supplier relationship you have to unwind after you have already built demand around it.

Research-use-only is a discipline, not a disclaimer

Operators sometimes treat "research use only" as a line of small print that neutralizes whatever the rest of the page says. It does not work that way. The designation only means anything if the whole operation is consistent with it.

In practice, that consistency looks like: product listings that describe the compound and the research context rather than what a person should do with it; no dosing tables, no administration guidance, no protocols; no before-and-after imagery; no implied outcomes for people; sales to businesses and research buyers rather than to consumers seeking personal use; and no pairing of compounds with injection supplies in a way that reads as a ready-to-use kit for a person.

It also applies upstream. If your supplier's own catalog is full of human-use language, dosing charts, or outcome promises, that posture becomes part of your supply chain story. When you evaluate a wholesale source, read its product pages the way a regulator would read yours. A vendor that is careless about framing in public is unlikely to be careful about anything you cannot see.

Where research is worth referencing at all, keep it honest and hedged. Studies indicate certain compounds are of interest for particular mechanistic questions; research suggests specific pathways warrant further investigation. That is a defensible sentence. "Proven to work" is not, and it does not belong anywhere near a catalog you intend to defend.

What changes when you buy at wholesale volume

Moving from occasional retail purchases to standing wholesale orders changes your exposure in ways worth planning for. You start holding inventory, which raises storage, handling, and shelf-life questions. You start reselling, which means your own documentation — not just your supplier's — becomes part of the record. And you start committing capital, which means a supplier problem is no longer a nuisance but a write-off.

Margins and order economics vary widely with volume, compound category, and how you position the product, so treat any vendor that promises you specific returns as a red flag rather than a partner. What a legitimate wholesale program can tell you is what the tiers are, what the minimums are, how fulfillment works, and what testing sits behind every lot. Those are knowable facts. Your profitability is not theirs to forecast.

What to verify before you commit to any supplier

The licensing question and the sourcing question get answered on the same timeline, because the quality of your documentation depends on your vendor. Before you sign anything, verify the following.

Certificates of analysis you can actually check. COAs should be published and tied to identifiable lots, not emailed on request after a complaint, and never sold as a paid add-on. If a supplier treats its own lab results as a premium feature, ask why.

Purity method, not just a purity number. Anyone can print a percentage. Ask what analytical method produced it and whether the report shows the chromatogram.

What the testing panel covers. Identity and purity are the starting point. Ask what else is screened on each batch and whether the same panel runs on every lot or only on samples.

Transparent pricing and stated minimums. Hidden pricing that only appears after a sales call makes it impossible to model your costs. Tiers, minimums, and fulfillment terms should be stated up front.

Domestic fulfillment and lead times you can plan around. Long international transit and customs exposure are real operational risks for a business holding inventory.

How the vendor responds to a human-use question. Ask directly what a person should take. A disciplined supplier will decline to answer. That refusal is the single most useful signal you will get.

What Real Peptides does differently

Real Peptides operates a Wholesale Partner Program built for businesses that need the paperwork to hold up. Every compound is tested to 99%+ HPLC purity, with multi-panel batch testing run on production lots rather than on a single representative sample. Certificates of analysis are publicly verifiable — a prospective buyer can look up lab results before spending anything, rather than taking a purity claim on faith or paying for the document that supports it.

Fulfillment is domestic, with orders shipping in five to seven days, which keeps inventory planning predictable and avoids customs exposure. Pricing tiers and minimums are stated rather than gated behind a discovery call. The wholesale application itself is three steps, so a qualified business can move from inquiry to an approved account without a drawn-out sales process.

Everything in the catalog is sold for laboratory research use only. That framing is consistent across the entire range, including the widely requested compounds in the popular peptides collection, and it holds in product copy, labeling, and support conversations. There are no dosing charts, no protocol guidance, and no human-use claims anywhere in the line — which is precisely what makes the sourcing defensible when you are the one reselling it.

Where to go from here

If you are an Indiana operator working through this, run the two tracks in parallel. Take your specific model — your labeling, your claims, your customer base — to an attorney and to the relevant state board, and get the licensure question answered on paper for your situation. At the same time, evaluate suppliers on evidence you can verify yourself rather than on assurances. Businesses that have their entity paperwork in order and have decided how they will describe what they sell are the ones the Wholesale Partner Program is built for.

For more detail, see the wholesale peptides program overview, the broader guide covering do you need a license to sell peptides, or apply for a wholesale account once your business registration and compliance review are complete.